The prevalence and clinical outcome of germline mutations in the BRCA1/2 and/or PALB2 genes in breast cancer patients in different ethnic groups, including populations from Turkey,26 Lebanon,27 Japan,28 Mexico,29 China,30, 31, 32 etc, have been widely reported recently. Here, BRCA1 is linked to breast cancer.